News & Press

Pharmawire Examines New FDA Guidelines on Combination Therapies

Pharmawire recently featured this article on the U.S. Food and Drug Administration’s (FDA) newly released draft guidelines for the co-development of combination therapies.  Reporter Elizabeth Krutoholow spoke with the Melanoma Research Foundation’s (MRF) executive director, Tim Turnham about the MRF’s efforts to support new discovery in melanoma research and some of the common challenges that arise when pharmaceutical companies seek to work together in finding new treatments.